4.7 Article

How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Role of the Endocannabinoid System in Metabolic Control Processes and in the Pathogenesis of Metabolic Syndrome: An Update

Gabriella Dornyei et al.

Summary: Metabolic syndrome is a complex disease state that arises from an unhealthy, sedentary lifestyle. It brings about various metabolic complications and reduces life expectancy. The endocannabinoid system plays a crucial role in signalization processes in both the central nervous system and peripheral tissues, affecting several physiological functions. Understanding cannabinoid receptor functions can offer potential therapeutic effects for the treatment of metabolic diseases like diabetes, insulin resistance, obesity, and hypertension.

BIOMEDICINES (2023)

Review Medicine, General & Internal

The Use of Cannabidiol in Metabolic Syndrome-An Opportunity to Improve the Patient's Health or Much Ado about Nothing?

Michal Wicinski et al.

Summary: Cannabis-derived therapies, particularly cannabidiol (CBD), have shown potential in the treatment of metabolic syndrome components such as obesity, impaired glucose and lipid metabolism, high blood pressure, and NAFLD. CBD has been found to have positive effects on glucose homeostasis, lipid disorders, and hypertension, but more research is needed. Limited data on CBD and NAFLD in human studies make it unclear whether CBD is beneficial for this condition.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity

Tomasz Charytoniuk et al.

Summary: It is known that metabolic disturbances, including obesity, increase the incidence of cardiovascular diseases. This study discovered that CBD treatment can inhibit the de novo ceramide synthesis pathway in the hearts of obese rats, leading to improved cardiac function.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats

Klaudia Berk et al.

Summary: Available data suggests that cannabidiol (CBD) can improve symptoms of insulin resistance by modulating sphingolipid concentrations. CBD reduces ceramide content in adipose tissues, enhancing insulin sensitivity. Therefore, CBD may be considered as a potential therapeutic strategy for treating insulin resistance and metabolic syndrome.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Integrative & Complementary Medicine

Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives

Fabrizio Calapai et al.

Summary: CBG is a non-psychotropic cannabinoid from Cannabis sativa that has various pharmacological effects, including reducing intraocular pressure, antioxidant, anti-inflammatory, and anti-tumoral activities. It is metabolized in the liver to produce hydroxyl and di-oxygenated products. CBG acts as a regulator of endocannabinoid signaling and has effects on multiple receptors.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2022)

Review Medicine, Research & Experimental

Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases

Hongyu Chen et al.

Summary: Sphingosine 1-phosphate receptor (S1PR), a G protein-coupled receptor, regulates the migration of various cells through the modulation of signals, pathways, and enzymes, making it a potential target for the treatment of autoimmune diseases, pulmonary disease, liver disease, and cancer.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Review Biochemistry & Molecular Biology

Trends in insulin resistance: insights into mechanisms and therapeutic strategy

Mengwei Li et al.

Summary: The centenary of insulin discovery provides an important opportunity to transform diabetes from a fatal diagnosis to a manageable chronic condition. Insulin resistance, associated with obesity, diabetes, and other abnormalities, is caused by abnormal biological response to insulin stimulation. Recent studies suggest that dysregulated metabolic mediators released by adipose tissue contribute to insulin resistance. Although there is no specific medication for insulin resistance, lifestyle changes and pharmacological interventions have been used to improve insulin sensitivity.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Medicine, Research & Experimental

Cannabidiol-A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance

Tomasz Charytoniuk et al.

Summary: The study investigated the effects of CBD on sphingolipid metabolism and brain insulin resistance, suggesting a potential protective role against neuropathology development. Results showed significant changes in sphingolipid concentrations and brain IR with CBD treatment.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Biochemistry & Molecular Biology

The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes

Hubert Zywno et al.

Summary: Coumestrol significantly reduces the accumulation of sphingolipids in insulin-resistant hepatocytes and promotes the expression of fatty acid transport proteins, improving hepatic insulin resistance. Additionally, Coumestrol alters the sphingolipid salvage pathway, leading to excessive sphingolipid deposition.

BIOMOLECULES (2021)

Article Nutrition & Dietetics

Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity

Patrycja Bielawiec et al.

Summary: Excessive intake of fatty acids leads to oxidative stress and inflammation, while CBD has potential therapeutic properties by improving the n-6/n-3 PUFA ratio, preventing lipid peroxidation, and attenuating inflammatory response in skeletal muscles.

NUTRIENTS (2021)

Review Pharmacology & Pharmacy

The Pharmacological Case for Cannabigerol

Rahul Nachnani et al.

Summary: Cannabigerol (CBG) is a unique phytocannabinoid with potential therapeutic properties in neurological, inflammatory bowel disease, and antibacterial activities. Despite its commercialization, limited research has been conducted on CBG, necessitating further exploration of its therapeutic uses and potential hazards.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)

Review Physiology

The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction

Mengyuan Ge et al.

FRONTIERS IN PHYSIOLOGY (2020)

Review Endocrinology & Metabolism

The Role of Ceramides in Insulin Resistance

Emilia Sokolowska et al.

FRONTIERS IN ENDOCRINOLOGY (2019)

Review Biochemistry & Molecular Biology

Sphingolipids in Obesity and Correlated Co-Morbidities: The Contribution of Gender, Age and Environment

Enrica Torretta et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Multidisciplinary Sciences

Sphingosine 1-phosphate: Lipid signaling in pathology and therapy

Andreane Cartier et al.

SCIENCE (2019)

Review Biochemistry & Molecular Biology

Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease

Burkhard Kleuser

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Hematology

Apolipoprotein M Protects Lipopolysaccharide-Treated Mice from Death and Organ Injury

Makoto Kurano et al.

THROMBOSIS AND HAEMOSTASIS (2018)

Article Pharmacology & Pharmacy

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes

Gemma Navarro et al.

FRONTIERS IN PHARMACOLOGY (2018)

Review Plant Sciences

Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history

Sara Anna Bonini et al.

JOURNAL OF ETHNOPHARMACOLOGY (2018)

Article Toxicology

Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis

Michelle M. Angrish et al.

TOXICOLOGICAL SCIENCES (2017)

Article Gastroenterology & Hepatology

Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate

Hiroyuki Nojima et al.

JOURNAL OF HEPATOLOGY (2016)

Article Biochemistry & Molecular Biology

Protective effects of fish oil on pre-diabetes: a lipidomic analysis of liver ceramides in rats

Nuria Taltavull et al.

FOOD & FUNCTION (2016)

Review Cell Biology

Sphingolipids in High Fat Diet and Obesity-Related Diseases

Songhwa Choi et al.

MEDIATORS OF INFLAMMATION (2015)

Article Multidisciplinary Sciences

New Evidence for the Role of Ceramide in the Development of Hepatic Insulin Resistance

Karolina Konstantynowicz-Nowicka et al.

PLOS ONE (2015)

Article Biochemical Research Methods

Stain-Free total protein staining is a superior loading control to β-actin for Western blots

Jennifer E. Gilda et al.

ANALYTICAL BIOCHEMISTRY (2013)

Article Pharmacology & Pharmacy

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease

Francesca Borrelli et al.

BIOCHEMICAL PHARMACOLOGY (2013)

Article Biochemistry & Molecular Biology

Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis

Golnar Karimian et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)

Article Biochemistry & Molecular Biology

The complexity of sphingolipid biosynthesis in the endoplasmic reticulum

Rotem Tidhar et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)

Review Behavioral Sciences

The role of the endocannabinoid system in eating disorders: pharmacological implications

Eva M. Marco et al.

BEHAVIOURAL PHARMACOLOGY (2012)

Article Neurosciences

A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis

Aitor G. Granja et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)

Article Physiology

Effect of exercise duration on ceramide metabolism in the rat heart

M. Baranowski et al.

ACTA PHYSIOLOGICA (2008)

Article Endocrinology & Metabolism

Intracellular Lipid Accumulation in Liver and Muscle and the Insulin Resistance Syndrome

Cristina Lara-Castro et al.

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)

Article Medicine, Research & Experimental

Chemical constituents of marijuana: The complex mixture of natural cannabinoids

MA ElSohly et al.

LIFE SCIENCES (2005)

Article Gastroenterology & Hepatology

The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance

ME Rinella et al.

JOURNAL OF HEPATOLOGY (2004)